These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15152790)

  • 21. [Increased risk of stroke during the use of olanzapine or risperidone in patients with dementia].
    van der Mast RC
    Ned Tijdschr Geneeskd; 2005 Mar; 149(13):726-7; author reply 727. PubMed ID: 15819141
    [No Abstract]   [Full Text] [Related]  

  • 22. [Increased risk of stroke during the use of olanzapine or risperidone in patients with dementia].
    Hafkamp GJ
    Ned Tijdschr Geneeskd; 2005 Mar; 149(13):726; author reply 727. PubMed ID: 15819140
    [No Abstract]   [Full Text] [Related]  

  • 23. Hypothermia associated with antipsychotic drug use: a clinical case series and review of current literature.
    Kreuzer P; Landgrebe M; Wittmann M; Schecklmann M; Poeppl TB; Hajak G; Langguth B
    J Clin Pharmacol; 2012 Jul; 52(7):1090-7. PubMed ID: 21956608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Severe recurrent hypothermia in an elderly patient with refractory mania associated with atypical antipsychotic, valproic acid and oxcarbazepine therapy.
    Ajayi OO; Holroyd S
    BMJ Case Rep; 2017 Dec; 2017():. PubMed ID: 29197846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bradycardia at low doses of risperidone.
    Tran KT; Golden P; Lark T; Jacob NJ
    Am J Psychiatry; 2004 Dec; 161(12):2325-6. PubMed ID: 15569911
    [No Abstract]   [Full Text] [Related]  

  • 26. Atypical antipsychotics and risk of cerebrovascular accidents.
    Herrmann N; Mamdani M; Lanctôt KL
    Am J Psychiatry; 2004 Jun; 161(6):1113-5. PubMed ID: 15169702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atypical antipsychotics for the treatment of dementia-related behaviors: an update.
    Daiello LA
    Med Health R I; 2007 Jun; 90(6):191-4. PubMed ID: 17633594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapidly developing hyperglycemia during treatment with olanzapine.
    Kohen I; Gampel M; Reddy L; Manu P
    Ann Pharmacother; 2008 Apr; 42(4):588-91. PubMed ID: 18364401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Olanzapine-associated bilateral eyelid edema.
    Zink M; Kuwilsky A; Knopf U
    J Clin Psychopharmacol; 2007 Apr; 27(2):214-5. PubMed ID: 17414232
    [No Abstract]   [Full Text] [Related]  

  • 30. Atypical antipsychotic use and parkinsonism in dementia: effects of drug, dose, and sex.
    Marras C; Herrmann N; Anderson GM; Fischer HD; Wang X; Rochon PA
    Am J Geriatr Pharmacother; 2012 Dec; 10(6):381-9. PubMed ID: 23217531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Olanzapine-induced leucopenia and neutropenia.
    Stergiou V; Bozikas VP; Garyfallos G; Nikolaidis N; Lavrentiadis G; Fokas K
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):992-4. PubMed ID: 15950350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can risperidone and olanzapine in elderly patients with dementia and other mental disorders be discontinued?
    Shah A
    Int J Geriatr Psychiatry; 2006 Feb; 21(2):140-6. PubMed ID: 16416461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the efficacy of new and conventional antipsychotic drugs in the treatment of behavioral and psychological symptoms of dementia (BPSD).
    Gareri P; Cotroneo A; Lacava R; Seminara G; Marigliano N; Loiacono A; De Sarro G
    Arch Gerontol Geriatr Suppl; 2004; (9):207-15. PubMed ID: 15207416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mortality in patients with dementia treated with atypical antipsychotics (olanzapine, quetiapine and ziprasidone).
    Martínez Martínez L; Olivera Fernández MR; Piñeiro Corrales G
    Farm Hosp; 2009; 33(4):224-8. PubMed ID: 19712611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary delusional parasitosis treated with olanzapine.
    Freudenmann RW; Schönfeldt-Lecuona C; Lepping P
    Int Psychogeriatr; 2007 Dec; 19(6):1161-8. PubMed ID: 17397562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of antipsychotics and benzodiazepines for dementia: Time for action? What will be required before global de-prescribing?
    Ralph SJ; Espinet AJ
    Dementia (London); 2019 Aug; 18(6):2322-2339. PubMed ID: 29271252
    [No Abstract]   [Full Text] [Related]  

  • 37. Olanzapine treatment of eight adolescent patients with psychosis.
    Ercan ES; Kutlu A; Varan A; Cikoğlu S; Coşkunol H; Bayraktar E
    Hum Psychopharmacol; 2004 Jan; 19(1):53-6. PubMed ID: 14716713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Increased risk of stroke during the use of olanzapine or risperidone in patients with dementia].
    van Marum RJ; Jansen PA
    Ned Tijdschr Geneeskd; 2005 Jan; 149(4):165-7. PubMed ID: 15702733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical effectiveness of atypical antipsychotics in dementia.
    Tariot PN
    J Clin Psychiatry; 2004; 65 Suppl 11():3-4. PubMed ID: 15264964
    [No Abstract]   [Full Text] [Related]  

  • 40. Case reports of postmarketing adverse event experiences with olanzapine intramuscular treatment in patients with agitation.
    Marder SR; Sorsaburu S; Dunayevich E; Karagianis JL; Dawe IC; Falk DM; Dellva MA; Carlson JL; Cavazzoni PA; Baker RW
    J Clin Psychiatry; 2010 Apr; 71(4):433-41. PubMed ID: 20156413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.